Transcriptomic analysis indicates that BCKDK downregulation alters multiple biological processes, including mTOR, ErbB, Hippo, and apoptosis signaling pathways, highlighting its critical role in RCC tumor progression. This evidence concerns the gene BCKDK and renal cell carcinoma.